These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 3060800)

  • 21. Accelerated deamination of cytosine residues in UV-induced cyclobutane pyrimidine dimers leads to CC-->TT transitions.
    Peng W; Shaw BR
    Biochemistry; 1996 Aug; 35(31):10172-81. PubMed ID: 8756482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p53-mediated transcription induces resistance of DNA to UV inactivation.
    Huang J; Logsdon N; Schmieg FI; Simmons DT
    Oncogene; 1998 Jul; 17(4):401-11. PubMed ID: 9696032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequency of active ras oncogenes in human bladder cancers associated with schistosomiasis.
    Fujita J; Nakayama H; Onoue H; Rhim JS; el-Bolkainy MN; el-Aaser AA; Kitamura Y
    Jpn J Cancer Res; 1987 Sep; 78(9):915-20. PubMed ID: 3117747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preferential and novel activation of H-ras in human bladder carcinomas.
    Visvanathan KV; Pocock RD; Summerhayes IC
    Oncogene Res; 1988; 3(1):77-86. PubMed ID: 3144694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolation of oncogenes from rat mammary tumors by a highly efficient retrovirus expression cloning system.
    Tsukamoto T; Huang T; Guzman RC; Chen X; Pascual RV; Kitamura T; Nandi S
    Biochem Biophys Res Commun; 1999 Nov; 265(1):7-12. PubMed ID: 10548482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transformation suppressor activity of C3G is independent of its CDC25-homology domain.
    Guerrero C; Fernandez-Medarde A; Rojas JM; Font de Mora J; Esteban LM; Santos E
    Oncogene; 1998 Feb; 16(5):613-24. PubMed ID: 9482107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The distribution of UV photoproducts along the human p53 gene and its relation to mutations in skin cancer.
    Tornaletti S; Rozek D; Pfeifer GP
    Oncogene; 1993 Aug; 8(8):2051-7. PubMed ID: 8336934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathogenicity of retroviruses containing either the normal human c-Ha-ras1 gene or its mutated form derived from the bladder carcinoma EJ/T24 cell line.
    Chang EH; Morgan PL; Lee EJ; Pirollo KF; White EA; Patrick DH; Tsichlis PN
    J Exp Pathol; 1985; 2(3):177-89. PubMed ID: 3842394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Photoreactivation does not alter ras and p53 mutation spectra in ultraviolet radiation-induced corneal sarcomas of Monodelphis domestica.
    Kusewitt DF; Preble NE; Bonnett CD
    Mol Carcinog; 2000 Feb; 27(2):117-24. PubMed ID: 10657904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.
    Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H
    Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequency of Ki-ras mutations and DNA alkylation in colorectal tissue from individuals living in Manchester.
    Jackson PE; Hall CN; Badawi AF; O'Connor PJ; Cooper DP; Povey AC
    Mol Carcinog; 1996 May; 16(1):12-9. PubMed ID: 8634090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation of stable CD4+ and CD8+ T cell lines from patients immunized with ras oncogene-derived peptides reflecting codon 12 mutations.
    Abrams SI; Khleif SN; Bergmann-Leitner ES; Kantor JA; Chung Y; Hamilton JM; Schlom J
    Cell Immunol; 1997 Dec; 182(2):137-51. PubMed ID: 9514698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ras oncogene activation in human ovarian carcinoma.
    van 't Veer LJ; Hermens R; van den Berg-Bakker LA; Cheng NC; Fleuren GJ; Bos JL; Cleton FJ; Schrier PI
    Oncogene; 1988 Feb; 2(2):157-65. PubMed ID: 3285294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ultraviolet light induces the expression of oncogenes in rat fibroblast and human keratinocyte cells.
    Ronai ZA; Okin E; Weinstein IB
    Oncogene; 1988 Feb; 2(2):201-4. PubMed ID: 3285298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sequence and time-dependent deamination of cytosine bases in UVB-induced cyclobutane pyrimidine dimers in vivo.
    Tu Y; Dammann R; Pfeifer GP
    J Mol Biol; 1998 Nov; 284(2):297-311. PubMed ID: 9813119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of activated ras oncogenes in human thyroid carcinomas.
    Suárez HG; Du Villard JA; Caillou B; Schlumberger M; Tubiana M; Parmentier C; Monier R
    Oncogene; 1988 Apr; 2(4):403-6. PubMed ID: 3283656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Repression of Myc-Ras cotransformation by Mad is mediated by multiple protein-protein interactions.
    Koskinen PJ; Ayer DE; Eisenman RN
    Cell Growth Differ; 1995 Jun; 6(6):623-9. PubMed ID: 7669717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of ras gene mutations and methylation state in human leukemias.
    Browett PJ; Norton JD
    Oncogene; 1989 Aug; 4(8):1029-36. PubMed ID: 2668844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. UV-induced DNA damage and mutations in Hupki (human p53 knock-in) mice recapitulate p53 hotspot alterations in sun-exposed human skin.
    Luo JL; Tong WM; Yoon JH; Hergenhahn M; Koomagi R; Yang Q; Galendo D; Pfeifer GP; Wang ZQ; Hollstein M
    Cancer Res; 2001 Nov; 61(22):8158-63. PubMed ID: 11719445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutant ras epitopes as targets for cancer vaccines.
    Abrams SI; Hand PH; Tsang KY; Schlom J
    Semin Oncol; 1996 Feb; 23(1):118-34. PubMed ID: 8607022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.